Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎Read how

Protean eGov Technologies debuts at IPO price on BSE

EditorAmbhini Aishwarya
Published 11/13/2023, 12:02 AM
© Reuters.

Protean eGov Technologies, a prominent player in India's e-governance sector, commenced trading on the Bombay Stock Exchange (BSE) on Monday, matching its initial public offering (IPO) price of ₹792 per share. The company's public issue had garnered significant interest from investors, being oversubscribed by nearly 24 times during the subscription period from November 6-8.

The IPO was purely an offer for sale of 61.9 lakh shares, with selling shareholders set to receive all proceeds since no new shares were issued. The successful management of the issue was led by a consortium including ICICI Securities, Equirus Capital, IIFL Securities, and Nomura Financial Advisory and Securities.

Despite trading at a ₹94 premium in the unlisted market prior to its debut, analysts from Mehta Equities have suggested that there may be limited upside potential due to the company's valuation. However, the market capitalization of Protean stands robust at ₹3,203 crore with a PE ratio of 29.9 times FY23 numbers.

Protean's recent financial performance underscores its strong position in the industry. For the quarter ending June 2023, the company reported a revenue increase of 40% to ₹220 crore (INR100 crore = approx. USD12 million) and a profit surge of 52% to ₹32.2 crore. Over its more than 25 years of operation, Protean has collaborated with seven Indian ministries to develop and implement 19 e-governance stacks that are crucial for digital public infrastructure and citizen-centric solutions.

The company's growth trajectory is supported by its diversified offerings that target new sectors and geographic expansion. As of June 30, 2023, it has been involved in executing projects that have shown a compound annual growth rate (CAGR) of 10.9 percent and 7.8 percent during FY21-23.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Among the noteworthy investors participating in Protean's offer-for-sale were HDFC Bank, Axis Bank, Union Bank of India, NSE Investments, and 360 One Special Opportunities Fund. Additionally, Protean holds a commanding market share in several sectors, including an impressive 100 percent in the Atal Pension Yojana (APY).

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.